Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rima Nabbout

Showing results (191-200 of 310) with videos related to

Pageof 31
Sort By:
Neurosurgery|January 26, 2023
Preoperative Detection of Subtle Focal Cortical Dysplasia in Children by Combined Arterial Spin Labeling, Voxel-Based Morphometry, Electroencephalography-Synchronized Functional MRI, Resting-State Regional Homogeneity, and 18F-fluorodeoxyglucose Positron Emission TomographyVolodia Dangouloff-Ros, Ludovic Fillon, Monika Eisermann, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trialPaolo Curatolo, David N Franz, John A Lawson, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 9, 2013
Early electro-clinical features may contribute to diagnosis of the anti-NMDA receptor encephalitis in childrenCyril Gitiaux, Hina Simonnet, Monika Eisermann, et al.
Journal of Clinical Pharmacology|May 17, 2021
Predictive Performance of Population Pharmacokinetic Models of Levetiracetam in Children and Evaluation of Dosing RegimenManon Tauzin, Jean-Marc Tréluyer, Rima Nabbout, et al.
Neurology. Clinical Practice|December 20, 2018
Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trialDavid N Franz, John A Lawson, Zuhal Yapici, et al.
Lancet (London, England)|September 11, 2016
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled studyJacqueline A French, John A Lawson, Zuhal Yapici, et al.
Frontiers in Pediatrics|March 22, 2021
West Syndrome Is an Exceptional Presentation of Pyridoxine- and Pyridoxal Phosphate-Dependent Epilepsy: Data From a French Cohort and Review of the LiteratureMarc Gibaud, Magalie Barth, Jérémie Lefranc, et al.
Epilepsia|December 8, 2018
Quantitative analysis and EEG markers of KCNT1 epilepsy of infancy with migrating focal seizuresMathieu Kuchenbuch, Pascal Benquet, Anna Kaminska, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 27, 2021
SYNGAP1-DEE: A visual sensitive epilepsyTommaso Lo Barco, Anna Kaminska, Roberta Solazzi, et al.
Epilepsy & Behavior : E&B|December 4, 2022
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopmentKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.
Pageof 31

Showing results (191-200 of 310) with videos related to

Sort By:
Pageof 31
Neurosurgery|January 26, 2023
Preoperative Detection of Subtle Focal Cortical Dysplasia in Children by Combined Arterial Spin Labeling, Voxel-Based Morphometry, Electroencephalography-Synchronized Functional MRI, Resting-State Regional Homogeneity, and 18F-fluorodeoxyglucose Positron Emission TomographyVolodia Dangouloff-Ros, Ludovic Fillon, Monika Eisermann, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trialPaolo Curatolo, David N Franz, John A Lawson, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 9, 2013
Early electro-clinical features may contribute to diagnosis of the anti-NMDA receptor encephalitis in childrenCyril Gitiaux, Hina Simonnet, Monika Eisermann, et al.
Journal of Clinical Pharmacology|May 17, 2021
Predictive Performance of Population Pharmacokinetic Models of Levetiracetam in Children and Evaluation of Dosing RegimenManon Tauzin, Jean-Marc Tréluyer, Rima Nabbout, et al.
Neurology. Clinical Practice|December 20, 2018
Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trialDavid N Franz, John A Lawson, Zuhal Yapici, et al.
Lancet (London, England)|September 11, 2016
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled studyJacqueline A French, John A Lawson, Zuhal Yapici, et al.
Frontiers in Pediatrics|March 22, 2021
West Syndrome Is an Exceptional Presentation of Pyridoxine- and Pyridoxal Phosphate-Dependent Epilepsy: Data From a French Cohort and Review of the LiteratureMarc Gibaud, Magalie Barth, Jérémie Lefranc, et al.
Epilepsia|December 8, 2018
Quantitative analysis and EEG markers of KCNT1 epilepsy of infancy with migrating focal seizuresMathieu Kuchenbuch, Pascal Benquet, Anna Kaminska, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 27, 2021
SYNGAP1-DEE: A visual sensitive epilepsyTommaso Lo Barco, Anna Kaminska, Roberta Solazzi, et al.
Epilepsy & Behavior : E&B|December 4, 2022
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopmentKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.
Pageof 31